391 related articles for article (PubMed ID: 23022268)
21. Silymarin inhibits melanoma cell growth both in vitro and in vivo by targeting cell cycle regulators, angiogenic biomarkers and induction of apoptosis.
Vaid M; Singh T; Prasad R; Katiyar SK
Mol Carcinog; 2015 Nov; 54(11):1328-39. PubMed ID: 25174976
[TBL] [Abstract][Full Text] [Related]
22. Antiproliferative and apoptotic effects of silibinin in rat prostate cancer cells.
Tyagi A; Bhatia N; Condon MS; Bosland MC; Agarwal C; Agarwal R
Prostate; 2002 Nov; 53(3):211-7. PubMed ID: 12386921
[TBL] [Abstract][Full Text] [Related]
23. Antiproliferative effect of resveratrol in pancreatic cancer cells.
Cui J; Sun R; Yu Y; Gou S; Zhao G; Wang C
Phytother Res; 2010 Nov; 24(11):1637-44. PubMed ID: 21031621
[TBL] [Abstract][Full Text] [Related]
24. Silibinin strongly inhibits growth and survival of human endothelial cells via cell cycle arrest and downregulation of survivin, Akt and NF-kappaB: implications for angioprevention and antiangiogenic therapy.
Singh RP; Dhanalakshmi S; Agarwal C; Agarwal R
Oncogene; 2005 Feb; 24(7):1188-202. PubMed ID: 15558015
[TBL] [Abstract][Full Text] [Related]
25. Antitumor Effects of Glychionide-A Flavonoid in Human Pancreatic Carcinoma Cells Are Mediated by Activation of Apoptotic and Autophagic Pathways, Cell Cycle Arrest, and Disruption of Mitochondrial Membrane Potential.
Yu L; Chen M; Zhang R; Xu T
Med Sci Monit; 2019 Feb; 25():962-969. PubMed ID: 30712054
[TBL] [Abstract][Full Text] [Related]
26. Anti-tumor activity of erlotinib in the BxPC-3 pancreatic cancer cell line.
Lu YY; Jing DD; Xu M; Wu K; Wang XP
World J Gastroenterol; 2008 Sep; 14(35):5403-11. PubMed ID: 18803351
[TBL] [Abstract][Full Text] [Related]
27. Silibinin inhibits the invasion and migration of renal carcinoma 786-O cells in vitro, inhibits the growth of xenografts in vivo and enhances chemosensitivity to 5-fluorouracil and paclitaxel.
Chang HR; Chen PN; Yang SF; Sun YS; Wu SW; Hung TW; Lian JD; Chu SC; Hsieh YS
Mol Carcinog; 2011 Oct; 50(10):811-23. PubMed ID: 21574189
[TBL] [Abstract][Full Text] [Related]
28. Eriocalyxin B induces apoptosis and cell cycle arrest in pancreatic adenocarcinoma cells through caspase- and p53-dependent pathways.
Li L; Yue GG; Lau CB; Sun H; Fung KP; Leung PC; Han Q; Leung PS
Toxicol Appl Pharmacol; 2012 Jul; 262(1):80-90. PubMed ID: 22561874
[TBL] [Abstract][Full Text] [Related]
29. Oridonin inhibition and miR‑200b‑3p/ZEB1 axis in human pancreatic cancer.
Gui Z; Luo F; Yang Y; Shen C; Li S; Xu J
Int J Oncol; 2017 Jan; 50(1):111-120. PubMed ID: 27878247
[TBL] [Abstract][Full Text] [Related]
30. Combination of HDAC inhibitor TSA and silibinin induces cell cycle arrest and apoptosis by targeting survivin and cyclinB1/Cdk1 in pancreatic cancer cells.
Feng W; Cai D; Zhang B; Lou G; Zou X
Biomed Pharmacother; 2015 Aug; 74():257-64. PubMed ID: 26349994
[TBL] [Abstract][Full Text] [Related]
31. Down-regulation of the nuclear factor-kappaB by lidamycin in association with inducing apoptosis in human pancreatic cancer cells and inhibiting xenograft growth.
Chen J; Ouyang ZG; Zhang SH; Zhen YS
Oncol Rep; 2007 Jun; 17(6):1445-51. PubMed ID: 17487403
[TBL] [Abstract][Full Text] [Related]
32. Rhizoma Paridis ethanol extract selectively inhibits the proliferation of HUVECs comparing to Lovo cells and shows anti-angiogenesis effects in a mouse model.
Qian X; Zhu L; Hu J; Li M; Xie L; Wang L; Yu L; Liu B
J Ethnopharmacol; 2012 Aug; 143(1):256-61. PubMed ID: 22750432
[TBL] [Abstract][Full Text] [Related]
33. Silibinin-mediated metabolic reprogramming attenuates pancreatic cancer-induced cachexia and tumor growth.
Shukla SK; Dasgupta A; Mehla K; Gunda V; Vernucci E; Souchek J; Goode G; King R; Mishra A; Rai I; Nagarajan S; Chaika NV; Yu F; Singh PK
Oncotarget; 2015 Dec; 6(38):41146-61. PubMed ID: 26510913
[TBL] [Abstract][Full Text] [Related]
34. Cellular and molecular mechanisms of silibinin induces cell-cycle arrest and apoptosis on HeLa cells.
Zhang Y; Ge Y; Chen Y; Li Q; Chen J; Dong Y; Shi W
Cell Biochem Funct; 2012 Apr; 30(3):243-8. PubMed ID: 22170400
[TBL] [Abstract][Full Text] [Related]
35. Oral silibinin inhibits lung tumor growth in athymic nude mice and forms a novel chemocombination with doxorubicin targeting nuclear factor kappaB-mediated inducible chemoresistance.
Singh RP; Mallikarjuna GU; Sharma G; Dhanalakshmi S; Tyagi AK; Chan DC; Agarwal C; Agarwal R
Clin Cancer Res; 2004 Dec; 10(24):8641-7. PubMed ID: 15623648
[TBL] [Abstract][Full Text] [Related]
36. Knockdown of ribosomal protein L39 by RNA interference inhibits the growth of human pancreatic cancer cells in vitro and in vivo.
Li C; Chen D; Luo M; Ge M; Zhu J
Biotechnol J; 2014 May; 9(5):652-63. PubMed ID: 24799381
[TBL] [Abstract][Full Text] [Related]
37. SB365, Pulsatilla saponin D suppresses proliferation and induces apoptosis of pancreatic cancer cells.
Son MK; Jung KH; Lee HS; Lee H; Kim SJ; Yan HH; Ryu YL; Hong SS
Oncol Rep; 2013 Aug; 30(2):801-8. PubMed ID: 23733203
[TBL] [Abstract][Full Text] [Related]
38. Antitumor efficacy of α-solanine against pancreatic cancer in vitro and in vivo.
Lv C; Kong H; Dong G; Liu L; Tong K; Sun H; Chen B; Zhang C; Zhou M
PLoS One; 2014; 9(2):e87868. PubMed ID: 24505326
[TBL] [Abstract][Full Text] [Related]
39. Silymarin and silibinin cause G1 and G2-M cell cycle arrest via distinct circuitries in human prostate cancer PC3 cells: a comparison of flavanone silibinin with flavanolignan mixture silymarin.
Deep G; Singh RP; Agarwal C; Kroll DJ; Agarwal R
Oncogene; 2006 Feb; 25(7):1053-69. PubMed ID: 16205633
[TBL] [Abstract][Full Text] [Related]
40. Ursolic acid inhibits colorectal cancer angiogenesis through suppression of multiple signaling pathways.
Lin J; Chen Y; Wei L; Hong Z; Sferra TJ; Peng J
Int J Oncol; 2013 Nov; 43(5):1666-74. PubMed ID: 24042330
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
